Lynn James Maland
Pharmacy in Salt Lake City, UT
License number
Utah 141568-1701
Issued Date
Jan 1, 1911
Expiration Date
Sep 30, 2017
Category
Pharmacy
Type
Pharmacist
Address
Address
Salt Lake City, UT
Personal information
See more information about Lynn James Maland at radaris.comName
Address
Phone
3470 S 3610 E, Salt Lake City, UT 84109
Holladay, UT
2121 Georgetown Sq, Salt Lake City, UT 84109
3470 3610Th A, Salt Lake City, UT 84109
3470 3610, Salt Lake Cty, UT 84109
Professional information
Sr. Dir Pharmaceutics At Cephalon
Position:
Sr. Dir Pharmaceutics at Cephalon
Location:
Greater Salt Lake City Area
Industry:
Pharmaceuticals
Work:
Cephalon
-
Sr. Dir Pharmaceutics
Education:
University of Utah 1967 - 1972
Separable Solid Dosage Form Administration System
US Patent:
2008013, Jun 5, 2008
Filed:
Nov 30, 2007
Appl. No.:
11/998706
Inventors:
Brian Hague - Salt Lake City UT, US
Lynn J. Maland - Salt Lake City UT, US
Lynn J. Maland - Salt Lake City UT, US
Assignee:
Cephalon, Inc. - Frazer PA
International Classification:
A61M 5/178, A61P 25/30, A61K 31/465
US Classification:
604 36, 514343
Abstract:
The invention described herein provides a solid dosage form administration system comprising: an oral solid dosage form containing an active ingredient; and a hand-held applicator; wherein the hand-held applicator is removably coupled to the dosage form. The system includes a reversible coupling structure permitting repeated engagement and disengagement of the dosage form component from the hand-held applicator component of the system. In one embodiment, the applicator is composed of a soft durometer flexible polymeric material. The invention can be used to administer various medicaments, and is especially useful in treatment of nicotine addiction.
Sugar-Free Oral Transmucosal Solid Dosage Forms And Uses Thereof
US Patent:
2004025, Dec 16, 2004
Filed:
Feb 3, 2004
Appl. No.:
10/771046
Inventors:
Brian Hague - Bountiful UT, US
Lynn Maland - Salt Lake City UT, US
Lynn Maland - Salt Lake City UT, US
International Classification:
A61K009/20
US Classification:
424/464000
Abstract:
The present invention is directed to oral solid dosage forms. The solid dosage forms are sugar-free, and comprise a pharmaceutical agent and a suitable pharmaceutically acceptable excipient. Preferably, the solid dosage forms of the present invention are bioequivalent to a sugar-containing solid dosage form. Bioequivalence is preferably obtained by incorporating an ionizing agent, more preferably in the form of a buffer system, into the solid dosage forms, in an amount sufficient to maintain a portion of the pharmaceutical agent, upon dissolution of said composition in saliva, in an ionized state.